+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Immune Disorders Drugs Market Research Reports

Asia Pacific Inflammatory Bowel Disease Treatment Market By Type, By Distribution Channel, By Route of Administration, By Drug Class, By Country, Opportunity Analysis and Industry Forecast, 2021 - 2027 - Product Thumbnail Image

Asia Pacific Inflammatory Bowel Disease Treatment Market By Type, By Distribution Channel, By Route of Administration, By Drug Class, By Country, Opportunity Analysis and Industry Forecast, 2021 - 2027

  • Report
  • October 2021
  • 124 Pages
  • Asia Pacific
From
North America Inflammatory Bowel Disease Treatment Market By Type, By Distribution Channel, By Route of Administration, By Drug Class, By Country, Opportunity Analysis and Industry Forecast, 2021 - 2027 - Product Thumbnail Image

North America Inflammatory Bowel Disease Treatment Market By Type, By Distribution Channel, By Route of Administration, By Drug Class, By Country, Opportunity Analysis and Industry Forecast, 2021 - 2027

  • Report
  • October 2021
  • 110 Pages
  • North America
From
Europe Inflammatory Bowel Disease Treatment Market By Type, By Distribution Channel, By Route of Administration, By Drug Class, By Country, Opportunity Analysis and Industry Forecast, 2021 - 2027 - Product Thumbnail Image

Europe Inflammatory Bowel Disease Treatment Market By Type, By Distribution Channel, By Route of Administration, By Drug Class, By Country, Opportunity Analysis and Industry Forecast, 2021 - 2027

  • Report
  • October 2021
  • 125 Pages
  • Europe
From
LAMEA Inflammatory Bowel Disease Treatment Market By Type, By Distribution Channel, By Route of Administration, By Drug Class, By Country, Opportunity Analysis and Industry Forecast, 2021 - 2027 - Product Thumbnail Image

LAMEA Inflammatory Bowel Disease Treatment Market By Type, By Distribution Channel, By Route of Administration, By Drug Class, By Country, Opportunity Analysis and Industry Forecast, 2021 - 2027

  • Report
  • October 2021
  • 124 Pages
  • Middle East, Africa
From
Inflammatory Bowel Disease Treatment Market By Type, By Distribution Channel, By Route of Administration, By Drug Class, By Regional Outlook, Industry Analysis Report and Forecast, 2021 - 2027 - Product Thumbnail Image

Inflammatory Bowel Disease Treatment Market By Type, By Distribution Channel, By Route of Administration, By Drug Class, By Regional Outlook, Industry Analysis Report and Forecast, 2021 - 2027

  • Report
  • October 2021
  • 288 Pages
  • Global
From
LAMEA Uveitis Treatment Market, by Drug Class, by Disease Type, by Distribution Channel, by Country, Industry Analysis and Forecast, 2019 - 2025 - Product Thumbnail Image

LAMEA Uveitis Treatment Market, by Drug Class, by Disease Type, by Distribution Channel, by Country, Industry Analysis and Forecast, 2019 - 2025

  • Report
  • March 2020
  • 90 Pages
  • Africa, Middle East
From
Allergy Treatment Market Report and Forecast 2023-2031 - Product Thumbnail Image

Allergy Treatment Market Report and Forecast 2023-2031

  • Report
  • April 2023
  • 160 Pages
  • Global
From
United Kingdom - Medicaments Containing Corticosteroid Hormones - Market Analysis, Forecast, Size, Trends and Insights - Product Thumbnail Image

United Kingdom - Medicaments Containing Corticosteroid Hormones - Market Analysis, Forecast, Size, Trends and Insights

  • Report
  • November 2024
  • United Kingdom
From
Smart Home Opportunity Assessment for Telcos - Product Thumbnail Image

Smart Home Opportunity Assessment for Telcos

  • Report
  • September 2018
  • 20 Pages
  • Global
From
Endometriosis Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update - Product Thumbnail Image

Endometriosis Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update

  • Report
  • July 2022
  • 161 Pages
  • Global
From
Fibromyalgia (Fibromyalgia Syndrome) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update - Product Thumbnail Image

Fibromyalgia (Fibromyalgia Syndrome) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update

  • Report
  • February 2022
  • 75 Pages
  • Global
From
Interleukin 11 (Adipogenesis Inhibitory Factor or Oprelvekin or IL11) - Drugs in Development, 2021 - Product Thumbnail Image

Interleukin 11 (Adipogenesis Inhibitory Factor or Oprelvekin or IL11) - Drugs in Development, 2021

  • Report
  • April 2021
  • 30 Pages
  • Global
From
Systemic Lupus Erythematosus - Pipeline Review, H2 2020 - Product Thumbnail Image

Systemic Lupus Erythematosus - Pipeline Review, H2 2020

  • Drug Pipelines
  • November 2020
  • 816 Pages
  • Global
From
Ulcerative Colitis - Pipeline Review, H2 2020 - Product Thumbnail Image

Ulcerative Colitis - Pipeline Review, H2 2020

  • Drug Pipelines
  • October 2020
  • 779 Pages
  • Global
From
Epidermolysis Bullosa - Pipeline Review, H2 2020 - Product Thumbnail Image

Epidermolysis Bullosa - Pipeline Review, H2 2020

  • Drug Pipelines
  • October 2020
  • 170 Pages
  • Global
From
Crohn's Disease (Regional Enteritis) - Pipeline Review, H2 2020 - Product Thumbnail Image

Crohn's Disease (Regional Enteritis) - Pipeline Review, H2 2020

  • Drug Pipelines
  • August 2020
  • 693 Pages
  • Global
From
Chemotherapy Induced Neutropenia - Pipeline Review, H2 2020 - Product Thumbnail Image

Chemotherapy Induced Neutropenia - Pipeline Review, H2 2020

  • Drug Pipelines
  • July 2020
  • 152 Pages
  • Global
From
Rheumatoid Arthritis - Pipeline Review, H2 2020 - Product Thumbnail Image

Rheumatoid Arthritis - Pipeline Review, H2 2020

  • Drug Pipelines
  • July 2020
  • 1191 Pages
  • Global
From
Alopecia - Pipeline Review, H2 2020 - Product Thumbnail Image

Alopecia - Pipeline Review, H2 2020

  • Drug Pipelines
  • July 2020
  • 222 Pages
  • Global
From
Mucopolysaccharidosis II (MPS II) (Hunter Syndrome ) - Pipeline Review, H1 2020 - Product Thumbnail Image

Mucopolysaccharidosis II (MPS II) (Hunter Syndrome ) - Pipeline Review, H1 2020

  • Drug Pipelines
  • June 2020
  • 71 Pages
  • Global
From
Loading Indicator

The Immune Disorders Drugs market is a sector of the pharmaceutical industry that focuses on the development and production of drugs to treat immune system disorders. These drugs are used to treat a variety of conditions, including allergies, asthma, autoimmune diseases, and cancer. Immune Disorders Drugs are designed to target specific parts of the immune system, such as cytokines, antibodies, and T-cells, to reduce inflammation and improve the body's ability to fight off infection. The Immune Disorders Drugs market is highly competitive, with many large pharmaceutical companies competing for market share. Some of the major players in the market include AbbVie, AstraZeneca, Bristol-Myers Squibb, GlaxoSmithKline, Merck, Novartis, Pfizer, and Roche. These companies are constantly researching and developing new drugs to treat immune system disorders, as well as improving existing treatments. Show Less Read more